Pain Sensitivity Questionnaire Applied in Preoperative Period in Lumpectomy
Lumpectomy
Prediction of Postoperative Pain Severity Using Pain Sensitivity Questionnaire Applied in Preoperative Period in Patients Undergoing Breast-Conserving Surgery (Lumpectomy)
2 other identifiers
observational
74
1 country
1
Brief Summary
Objective: The Pain Sensitivity Questionnaire (PSQ) is a clinically valuable tool that has been shown to correlate with various experimental pain sensitivity assessments in healthy individuals and patients with chronic pain. In this study, we aimed to investigate the effectiveness of the PSQ in predicting postoperative pain in patients undergoing breast-conserving surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2024
CompletedFirst Submitted
Initial submission to the registry
March 20, 2025
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedApril 15, 2025
April 1, 2025
6 months
March 20, 2025
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction of Postoperative Pain Severity Using Pain Sensitivity Questionnaire Applied in Preoperative Period in Patients Undergoing Lumpectomy
This study included 74 patients over the age of 18 with American Society of Anesthesiologists (ASA) scores of I, II, or III, who were scheduled to undergo breast-conserving surgery. Ethical approval from the local ethics committee and written informed consent from each patient were obtained. Patient data, including age, ASA score, and comorbidities, were collected, and contact details were recorded for postoperative follow-up.The aim was to examine the relationship between the PSQ score measured in the preoperative period and the degree of pain in the postoperative period. BPI score and NRS score were used in the evaluation of postoperative pain.
From March 2024 to August 2024
Study Arms (1)
Having planned BCS with general anesthesia • Being a female patient between the ages of 18-70
Having planned BCS with general anesthesia Being a female patient between the ages of 18-70 Being evaluated as American Society of Anesthesiologists (ASA) I, II, III Having given written consent to participate in the study
Interventions
: This study included 74 patients over the age of 18 with American Society of Anesthesiologists (ASA) scores of I, II, or III, who were scheduled to undergo breast-conserving surgery. Ethical approval from the local ethics committee and written informed consent from each patient were obtained. Patient data, including age, ASA score, and comorbidities, were collected, and contact details were recorded for postoperative follow-up. The PSQ was administered to all patients during the preoperative period to assess their pain sensitivity. Anesthesia induction and maintenance followed a standardized protocol on the day of surgery. The intraoperative analgesic consumption and the duration of the surgery were documented. Postoperative assessments were conducted 24 hours after the surgery in the general surgery ward, where analgesic use and short pain inventory scores were recorded. Patients were followed up one month postoperatively, and their pain levels were assessed using the Numeric Rating
Eligibility Criteria
Patients between the ages of 18-70 who are scheduled for breast-conserving surgery
You may qualify if:
- Having planned BCS with general anesthesia
- Being a female patient between the ages of 18-70
- Being evaluated as American Society of Anesthesiologists (ASA) I, II, III
- Having given written consent to participate in the study
You may not qualify if:
- Pregnancy
- Being assessed as ASA IV
- Having advanced cardiac, pulmonary and cerebrovascular disease, advanced renal failure, liver failure, history of fentanyl/remifentanyl hypersensitivity, Alzheimer's disease, mental retardation
- Being at a mental level that cannot comply with the evaluations within the scope of the study
- Not having given written consent for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Lutfi Kirdar City Hospital
Istanbul, 34870, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
BANU CEVIK, PROFFESSOR
DR LUTFI KIRDAR CITY HOSPİTAL
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor
Study Record Dates
First Submitted
March 20, 2025
First Posted
April 15, 2025
Study Start
March 1, 2024
Primary Completion
August 31, 2024
Study Completion
October 23, 2024
Last Updated
April 15, 2025
Record last verified: 2025-04